Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Prevalence of hemoprotozoan parasites in small ruminants along a human-livestock-wildlife interface in western Uganda.

Kasozi KI, Namayanja M, Gaithuma AK, Mahero M, Matovu E, Yamagishi J, Sugimoto C, MacLeod E.

Vet Parasitol Reg Stud Reports. 2019 Aug;17:100309. doi: 10.1016/j.vprsr.2019.100309. Epub 2019 May 31.

PMID:
31303220
2.

Characterization of Evolutionarily Conserved Trypanosoma cruzi NatC and NatA-N-Terminal Acetyltransferase Complexes.

Ochaya S, Franzén O, Buhwa DA, Foyn H, Butler CE, Stove SI, Tyler KM, Arnesen T, Matovu E, Åslund L, Andersson B.

J Parasitol Res. 2019 Mar 6;2019:6594212. doi: 10.1155/2019/6594212. eCollection 2019.

3.

Macrophage migrating inhibitory factor expression is associated with Trypanosoma brucei gambiense infection and is controlled by trans-acting expression quantitative trait loci in the Guinean population.

Kaboré JW, Camara O, Ilboudo H, Capewell P, Clucas C, Cooper A, Kaboré J, Camara M, Jamonneau V, Hertz-Fowler C, Bélem AMG, Matovu E, Macleod A, Sidibé I, Noyes H, Bucheton B; TrypanoGEN Research Group, as member of the H3Africa Consortium.

Infect Genet Evol. 2019 Jul;71:108-115. doi: 10.1016/j.meegid.2019.03.021. Epub 2019 Mar 23.

PMID:
30914286
4.

Association between IL1 gene polymorphism and human African trypanosomiasis in populations of sleeping sickness foci of southern Cameroon.

Ofon E, Noyes H, Ebo'o Eyanga V, Njiokou F, Koffi M, Fogue P, Hertz-Fowler C, MacLeod A, Matovu E, Simo G; TrypanoGEN Research Group, as members of The H3Africa Consortium.

PLoS Negl Trop Dis. 2019 Mar 25;13(3):e0007283. doi: 10.1371/journal.pntd.0007283. eCollection 2019 Mar.

5.

AcSDKP is down-regulated in anaemia induced by Trypanosoma brucei infection in mice.

Musaya J, Matovu E, Senga E, Nyirenda M, Chisi J.

Malawi Med J. 2017 Sep;29(3):259-264. doi: 10.4314/mmj.v29i3.6.

6.

Strengthening human genetics research in Africa: report of the 9th meeting of the African Society of Human Genetics in Dakar in May 2016.

Ndiaye Diallo R, Gadji M, Hennig BJ, Guèye MV, Gaye A, Diop JPD, Sylla Niang M, Lopez Sall P, Guèye PM, Dem A, Faye O, Dieye A, Cisse A, Sembene M, Ka S, Diop N, Williams SM, Matovu E, Ramesar RS, Wonkam A, Newport M, Rotimi C, Ramsay M.

Glob Health Epidemiol Genom. 2017 Aug 4;2:e10. doi: 10.1017/gheg.2017.3. eCollection 2017.

7.

Transcriptomes of Trypanosoma brucei rhodesiense from sleeping sickness patients, rodents and culture: Effects of strain, growth conditions and RNA preparation methods.

Mulindwa J, Leiss K, Ibberson D, Kamanyi Marucha K, Helbig C, Melo do Nascimento L, Silvester E, Matthews K, Matovu E, Enyaru J, Clayton C.

PLoS Negl Trop Dis. 2018 Feb 23;12(2):e0006280. doi: 10.1371/journal.pntd.0006280. eCollection 2018 Feb.

8.

A multicentre, randomised, non-inferiority clinical trial comparing a nifurtimox-eflornithine combination to standard eflornithine monotherapy for late stage Trypanosoma brucei gambiense human African trypanosomiasis in Uganda.

Kansiime F, Adibaku S, Wamboga C, Idi F, Kato CD, Yamuah L, Vaillant M, Kioy D, Olliaro P, Matovu E.

Parasit Vectors. 2018 Feb 22;11(1):105. doi: 10.1186/s13071-018-2634-x.

9.

No evidence for association between APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations.

Kimuda MP, Noyes H, Mulindwa J, Enyaru J, Alibu VP, Sidibe I, Mumba Ngoyi D, Hertz-Fowler C, MacLeod A, Tastan Bishop Ö, Matovu E; TrypanoGEN Research Group as members of The H3Africa Consortium.

PLoS Negl Trop Dis. 2018 Feb 22;12(2):e0006300. doi: 10.1371/journal.pntd.0006300. eCollection 2018 Feb.

10.

Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination?

Informal Expert Group on Gambiense HAT Reservoirs, Büscher P, Bart JM, Boelaert M, Bucheton B, Cecchi G, Chitnis N, Courtin D, Figueiredo LM, Franco JR, Grébaut P, Hasker E, Ilboudo H, Jamonneau V, Koffi M, Lejon V, MacLeod A, Masumu J, Matovu E, Mattioli R, Noyes H, Picado A, Rock KS, Rotureau B, Simo G, Thévenon S, Trindade S, Truc P, Van Reet N.

Trends Parasitol. 2018 Mar;34(3):197-207. doi: 10.1016/j.pt.2017.11.008. Epub 2018 Jan 23. Review.

11.

Serological tests for gambiense human African trypanosomiasis detect antibodies in cattle.

Matovu E, Kitibwa A, Picado A, Biéler S, Bessell PR, Ndung'u JM.

Parasit Vectors. 2017 Nov 3;10(1):546. doi: 10.1186/s13071-017-2487-8.

12.

Relationship between Trypanosoma brucei rhodesiense genetic diversity and clinical spectrum among sleeping sickness patients in Uganda.

Kato CD, Mugasa CM, Nanteza A, Matovu E, Alibu VP.

BMC Res Notes. 2017 Oct 27;10(1):518. doi: 10.1186/s13104-017-2860-x.

13.

Candidate genes-based investigation of susceptibility to Human African Trypanosomiasis in Côte d'Ivoire.

Ahouty B, Koffi M, Ilboudo H, Simo G, Matovu E, Mulindwa J, Hertz-Fowler C, Bucheton B, Sidibé I, Jamonneau V, MacLeod A, Noyes H, N'Guetta SP; TrypanoGEN Research Group as members of The H3Africa Consortium.

PLoS Negl Trop Dis. 2017 Oct 23;11(10):e0005992. doi: 10.1371/journal.pntd.0005992. eCollection 2017 Oct.

14.

Enhanced passive screening and diagnosis for gambiense human African trypanosomiasis in north-western Uganda - Moving towards elimination.

Wamboga C, Matovu E, Bessell PR, Picado A, Biéler S, Ndung'u JM.

PLoS One. 2017 Oct 12;12(10):e0186429. doi: 10.1371/journal.pone.0186429. eCollection 2017.

15.

Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea.

Kaboré JW, Ilboudo H, Noyes H, Camara O, Kaboré J, Camara M, Koffi M, Lejon V, Jamonneau V, MacLeod A, Hertz-Fowler C, Belem AMG, Matovu E, Bucheton B, Sidibe I; TrypanoGEN Research Group as members of The H3Africa Consortium.

PLoS Negl Trop Dis. 2017 Aug 21;11(8):e0005833. doi: 10.1371/journal.pntd.0005833. eCollection 2017 Aug.

16.

Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis.

Ilboudo H, Noyes H, Mulindwa J, Kimuda MP, Koffi M, Kaboré JW, Ahouty B, Ngoyi DM, Fataki O, Simo G, Ofon E, Enyaru J, Chisi J, Kamoto K, Simuunza M, Alibu VP, Lejon V, Jamonneau V, Macleod A, Camara M, Bucheton B, Hertz-Fowler C, Sidibe I, Matovu E; TrypanoGEN Research Group as members of The H3Africa Consortium.

PLoS Negl Trop Dis. 2017 Jun 1;11(6):e0005438. doi: 10.1371/journal.pntd.0005438. eCollection 2017 Jun. No abstract available.

17.

Polymerase chain reaction identification of Trypanosoma brucei rhodesiense in wild tsetse flies from Nkhotakota Wildlife Reserve, Malawi.

Musaya J, Chisi J, Senga E, Nambala P, Maganga E, Matovu E, Enyaru J.

Malawi Med J. 2017 Mar;29(1):5-9.

18.

APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis.

Cooper A, Ilboudo H, Alibu VP, Ravel S, Enyaru J, Weir W, Noyes H, Capewell P, Camara M, Milet J, Jamonneau V, Camara O, Matovu E, Bucheton B, MacLeod A.

Elife. 2017 May 24;6. pii: e25461. doi: 10.7554/eLife.25461.

19.

Trypanosoma brucei brucei traverses different biological barriers differently and may modify the host plasma membrane in the process.

Namayanja M, Dai Y, Nerima B, Matovu E, Lun ZR, Lubega GW, Zhengjun C.

Exp Parasitol. 2017 Mar;174:31-41. doi: 10.1016/j.exppara.2016.12.012. Epub 2016 Dec 20.

PMID:
28011167
20.

Population genetic structure and temporal stability among Trypanosoma brucei rhodesiense isolates in Uganda.

Kato CD, Alibu VP, Nanteza A, Mugasa CM, Matovu E.

Parasit Vectors. 2016 May 3;9:259. doi: 10.1186/s13071-016-1542-1.

21.

Characterization of Calflagin, a Flagellar Calcium-Binding Protein from Trypanosoma congolense.

Eyford BA, Kaufman L, Salama-Alber O, Loveless B, Pope ME, Burke RD, Matovu E, Boulanger MJ, Pearson TW.

PLoS Negl Trop Dis. 2016 Apr 7;10(4):e0004510. doi: 10.1371/journal.pntd.0004510. eCollection 2016 Apr.

22.

The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness.

Kato CD, Matovu E, Mugasa CM, Nanteza A, Alibu VP.

Allergy Asthma Clin Immunol. 2016 Jan 22;12:4. doi: 10.1186/s13223-016-0113-5. eCollection 2016. Review.

23.

Transcriptomes of newly-isolated Trypanosoma brucei rhodesiense reveal hundreds of mRNAs that are co-regulated with stumpy-form markers.

Mulindwa J, Mercé C, Matovu E, Enyaru J, Clayton C.

BMC Genomics. 2015 Dec 29;16:1118. doi: 10.1186/s12864-015-2338-y.

24.

Role of cytokines in Trypanosoma brucei-induced anaemia: A review of the literature.

Musaya J, Matovu E, Nyirenda M, Chisi J.

Malawi Med J. 2015 Jun;27(2):45-50. Review.

25.

Human brucellosis: sero-prevalence and associated risk factors in agro-pastoral communities of Kiboga District, Central Uganda.

Tumwine G, Matovu E, Kabasa JD, Owiny DO, Majalija S.

BMC Public Health. 2015 Sep 15;15:900. doi: 10.1186/s12889-015-2242-z.

26.

Interleukin (IL)-6 and IL-10 Are Up Regulated in Late Stage Trypanosoma brucei rhodesiense Sleeping Sickness.

Kato CD, Alibu VP, Nanteza A, Mugasa CM, Matovu E.

PLoS Negl Trop Dis. 2015 Jun 19;9(6):e0003835. doi: 10.1371/journal.pntd.0003835. eCollection 2015 Jun.

27.

Use of real time polymerase chain reaction for detection of M. tuberculosis, M. avium and M. kansasii from clinical specimens.

Bainomugisa A, Wampande E, Muchwa C, Akol J, Mubiri P, Ssenyungule H, Matovu E, Ogwang S, Joloba M.

BMC Infect Dis. 2015 Apr 14;15:181. doi: 10.1186/s12879-015-0921-0.

28.

Clinical profiles, disease outcome and co-morbidities among T. b. rhodesiense sleeping sickness patients in Uganda.

Kato CD, Nanteza A, Mugasa C, Edyelu A, Matovu E, Alibu VP.

PLoS One. 2015 Feb 26;10(2):e0118370. doi: 10.1371/journal.pone.0118370. eCollection 2015.

29.

Research capacity. Enabling the genomic revolution in Africa.

H3Africa Consortium, Rotimi C, Abayomi A, Abimiku A, Adabayeri VM, Adebamowo C, Adebiyi E, Ademola AD, Adeyemo A, Adu D, Affolabi D, Agongo G, Ajayi S, Akarolo-Anthony S, Akinyemi R, Akpalu A, Alberts M, Alonso Betancourt O, Alzohairy AM, Ameni G, Amodu O, Anabwani G, Andersen K, Arogundade F, Arulogun O, Asogun D, Bakare R, Balde N, Baniecki ML, Beiswanger C, Benkahla A, Bethke L, Boehnke M, Boima V, Brandful J, Brooks AI, Brosius FC, Brown C, Bucheton B, Burke DT, Burnett BG, Carrington-Lawrence S, Carstens N, Chisi J, Christoffels A, Cooper R, Cordell H, Crowther N, Croxton T, de Vries J, Derr L, Donkor P, Doumbia S, Duncanson A, Ekem I, El Sayed A, Engel ME, Enyaru JC, Everett D, Fadlelmola FM, Fakunle E, Fischbeck KH, Fischer A, Folarin O, Gamieldien J, Garry RF, Gaseitsiwe S, Gbadegesin R, Ghansah A, Giovanni M, Goesbeck P, Gomez-Olive FX, Grant DS, Grewal R, Guyer M, Hanchard NA, Happi CT, Hazelhurst S, Hennig BJ, Hertz- C, Fowler, Hide W, Hilderbrandt F, Hugo-Hamman C, Ibrahim ME, James R, Jaufeerally-Fakim Y, Jenkins C, Jentsch U, Jiang PP, Joloba M, Jongeneel V, Joubert F, Kader M, Kahn K, Kaleebu P, Kapiga SH, Kassim SK, Kasvosve I, Kayondo J, Keavney B, Kekitiinwa A, Khan SH, Kimmel P, King MC, Kleta R, Koffi M, Kopp J, Kretzler M, Kumuthini J, Kyobe S, Kyobutungi C, Lackland DT, Lacourciere KA, Landouré G, Lawlor R, Lehner T, Lesosky M, Levitt N, Littler K, Lombard Z, Loring JF, Lyantagaye S, Macleod A, Madden EB, Mahomva CR, Makani J, Mamven M, Marape M, Mardon G, Marshall P, Martin DP, Masiga D, Mason R, Mate-Kole M, Matovu E, Mayige M, Mayosi BM, Mbanya JC, McCurdy SA, McCarthy MI, McIlleron H, Mc'Ligeyo SO, Merle C, Mocumbi AO, Mondo C, Moran JV, Motala A, Moxey-Mims M, Mpoloka WS, Msefula CL, Mthiyane T, Mulder N, Mulugeta Gh, Mumba D, Musuku J, Nagdee M, Nash O, Ndiaye D, Nguyen AQ, Nicol M, Nkomazana O, Norris S, Nsangi B, Nyarko A, Nyirenda M, Obe E, Obiakor R, Oduro A, Ofori-Acquah SF, Ogah O, Ogendo S, Ohene-Frempong K, Ojo A, Olanrewaju T, Oli J, Osafo C, Ouwe Missi Oukem-Boyer O, Ovbiagele B, Owen A, Owolabi MO, Owolabi L, Owusu-Dabo E, Pare G, Parekh R, Patterton HG, Penno MB, Peterson J, Pieper R, Plange-Rhule J, Pollak M, Puzak J, Ramesar RS, Ramsay M, Rasooly R, Reddy S, Sabeti PC, Sagoe K, Salako T, Samassékou O, Sandhu MS, Sankoh O, Sarfo FS, Sarr M, Shaboodien G, Sidibe I, Simo G, Simuunza M, Smeeth L, Sobngwi E, Soodyall H, Sorgho H, Sow Bah O, Srinivasan S, Stein DJ, Susser ES, Swanepoel C, Tangwa G, Tareila A, Tastan Bishop O, Tayo B, Tiffin N, Tinto H, Tobin E, Tollman SM, Traoré M, Treadwell MJ, Troyer J, Tsimako-Johnstone M, Tukei V, Ulasi I, Ulenga N, van Rooyen B, Wachinou AP, Waddy SP, Wade A, Wayengera M, Whitworth J, Wideroff L, Winkler CA, Winnicki S, Wonkam A, Yewondwos M, sen T, Yozwiak N, Zar H.

Science. 2014 Jun 20;344(6190):1346-8. doi: 10.1126/science.1251546. No abstract available.

30.

Methods to determine the transcriptomes of trypanosomes in mixtures with mammalian cells: the effects of parasite purification and selective cDNA amplification.

Mulindwa J, Fadda A, Merce C, Matovu E, Enyaru J, Clayton C.

PLoS Negl Trop Dis. 2014 Apr 17;8(4):e2806. doi: 10.1371/journal.pntd.0002806. eCollection 2014 Apr.

31.

Comparison of nucleic acid sequence-based amplification and loop-mediated isothermal amplification for diagnosis of human African trypanosomiasis.

Mugasa CM, Katiti D, Boobo A, Lubega GW, Schallig HD, Matovu E.

Diagn Microbiol Infect Dis. 2014 Feb;78(2):144-8. doi: 10.1016/j.diagmicrobio.2013.06.025.

PMID:
24439269
32.

Identification of coding sequences from a freshly prepared Trypanosoma brucei brucei expression library by polymerase chain reaction.

Okalang U, Nanteza A, Matovu E, Lubega GW.

Int J Biochem Mol Biol. 2013 Jul 29;4(2):73-82. Print 2013.

33.

Comparative diagnostic and analytical performance of PCR and LAMP-based trypanosome detection methods estimated using pooled whole tsetse flies and midguts.

Malele II, Ouma JO, Enyaru JC, Matovu E, Alibu V, Auma JE, Onyoyo SG, Bateta R, Changasi RE, Mukiria PW, Ndung'u K, Gitonga PK, Mwaniki LM, Nyingilili HS, Lyaruu EA, Kapange LA, Kamau PK, Masiga DK.

Vet Parasitol. 2013 Nov 8;197(3-4):549-56. doi: 10.1016/j.vetpar.2013.05.022. Epub 2013 Jun 6.

PMID:
23796572
34.

Neopterin is a cerebrospinal fluid marker for treatment outcome evaluation in patients affected by Trypanosoma brucei gambiense sleeping sickness.

Tiberti N, Lejon V, Hainard A, Courtioux B, Robin X, Turck N, Kristensson K, Matovu E, Enyaru JC, Mumba Ngoyi D, Krishna S, Bisser S, Ndung'u JM, Büscher P, Sanchez JC.

PLoS Negl Trop Dis. 2013;7(2):e2088. doi: 10.1371/journal.pntd.0002088. Epub 2013 Feb 28.

35.

New biomarkers for stage determination in Trypanosoma brucei rhodesiense sleeping sickness patients.

Tiberti N, Matovu E, Hainard A, Enyaru JC, Lejon V, Robin X, Turck N, Ngoyi DM, Krishna S, Bisser S, Courtioux B, Büscher P, Kristensson K, Ndung'u JM, Sanchez JC.

Clin Transl Med. 2013 Jan 7;2(1):1. doi: 10.1186/2001-1326-2-1.

36.

Cerebrospinal fluid neopterin as marker of the meningo-encephalitic stage of Trypanosoma brucei gambiense sleeping sickness.

Tiberti N, Hainard A, Lejon V, Courtioux B, Matovu E, Enyaru JC, Robin X, Turck N, Kristensson K, Ngoyi DM, Vatunga GM, Krishna S, Büscher P, Bisser S, Ndung'u JM, Sanchez JC.

PLoS One. 2012;7(7):e40909. doi: 10.1371/journal.pone.0040909. Epub 2012 Jul 18.

37.

Towards Point-of-Care Diagnostic and Staging Tools for Human African Trypanosomiaisis.

Matovu E, Kazibwe AJ, Mugasa CM, Ndungu JM, Njiru ZK.

J Trop Med. 2012;2012:340538. doi: 10.1155/2012/340538. Epub 2012 Mar 27.

38.

Improved detection of Trypanosoma brucei by lysis of red blood cells, concentration and LED fluorescence microscopy.

Biéler S, Matovu E, Mitashi P, Ssewannyana E, Bi Shamamba SK, Bessell PR, Ndung'u JM.

Acta Trop. 2012 Feb;121(2):135-40. doi: 10.1016/j.actatropica.2011.10.016. Epub 2011 Nov 4.

PMID:
22079374
39.

Drug resistance in human African trypanosomiasis.

Barrett MP, Vincent IM, Burchmore RJ, Kazibwe AJ, Matovu E.

Future Microbiol. 2011 Sep;6(9):1037-47. doi: 10.2217/fmb.11.88. Review.

PMID:
21958143
40.

The diamidine diminazene aceturate is a substrate for the high-affinity pentamidine transporter: implications for the development of high resistance levels in trypanosomes.

Teka IA, Kazibwe AJ, El-Sabbagh N, Al-Salabi MI, Ward CP, Eze AA, Munday JC, Mäser P, Matovu E, Barrett MP, de Koning HP.

Mol Pharmacol. 2011 Jul;80(1):110-6. doi: 10.1124/mol.111.071555. Epub 2011 Mar 24.

41.

Detection of Group 1 Trypanosoma brucei gambiense by loop-mediated isothermal amplification.

Njiru ZK, Traub R, Ouma JO, Enyaru JC, Matovu E.

J Clin Microbiol. 2011 Apr;49(4):1530-6. doi: 10.1128/JCM.01817-10. Epub 2011 Feb 9.

42.

Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis.

Hainard A, Tiberti N, Robin X, Ngoyi DM, Matovu E, Enyaru JC, Müller M, Turck N, Ndung'u JM, Lejon V, Sanchez JC.

Trop Med Int Health. 2011 Jan;16(1):119-26. doi: 10.1111/j.1365-3156.2010.02642.x. Epub 2010 Oct 19.

43.

Discovery and verification of osteopontin and Beta-2-microglobulin as promising markers for staging human African trypanosomiasis.

Tiberti N, Hainard A, Lejon V, Robin X, Ngoyi DM, Turck N, Matovu E, Enyaru J, Ndung'u JM, Scherl A, Dayon L, Sanchez JC.

Mol Cell Proteomics. 2010 Dec;9(12):2783-95. doi: 10.1074/mcp.M110.001008. Epub 2010 Aug 19.

44.

Phase II evaluation of sensitivity and specificity of PCR and NASBA followed by oligochromatography for diagnosis of human African trypanosomiasis in clinical samples from D.R. Congo and Uganda.

Matovu E, Mugasa CM, Ekangu RA, Deborggraeve S, Lubega GW, Laurent T, Schoone GJ, Schallig HD, Büscher P.

PLoS Negl Trop Dis. 2010 Jul 6;4(7):e737. doi: 10.1371/journal.pntd.0000737.

45.

Landmarks in the evolution of technologies for identifying trypanosomes in tsetse flies.

Enyaru JC, Ouma JO, Malele II, Matovu E, Masiga DK.

Trends Parasitol. 2010 Aug;26(8):388-94. doi: 10.1016/j.pt.2010.04.011. Epub 2010 Jun 9. Review.

PMID:
20542733
46.

Sensitivity and specificity of the Leishmania OligoC-TesT and NASBA-oligochromatography for diagnosis of visceral leishmaniasis in Kenya.

Basiye FL, Mbuchi M, Magiri C, Kirigi G, Deborggraeve S, Schoone GJ, Saad AA, El-Safi S, Matovu E, Wasunna MK.

Trop Med Int Health. 2010 Jul;15(7):806-10. doi: 10.1111/j.1365-3156.2010.02548.x. Epub 2010 May 14.

47.

Comparative detection of trypanosomal DNA by loop-mediated isothermal amplification and PCR from flinders technology associates cards spotted with patient blood.

Matovu E, Kuepfer I, Boobo A, Kibona S, Burri C.

J Clin Microbiol. 2010 Jun;48(6):2087-90. doi: 10.1128/JCM.00101-10. Epub 2010 Apr 21.

48.

A search for Trypanosoma brucei rhodesiense diagnostic antigens by proteomic screening and targeted cloning.

Manful T, Mulindwa J, Frank FM, Clayton CE, Matovu E.

PLoS One. 2010 Mar 10;5(3):e9630. doi: 10.1371/journal.pone.0009630.

49.

Genotypic status of the TbAT1/P2 adenosine transporter of Trypanosoma brucei gambiense isolates from Northwestern Uganda following melarsoprol withdrawal.

Kazibwe AJ, Nerima B, de Koning HP, Mäser P, Barrett MP, Matovu E.

PLoS Negl Trop Dis. 2009 Sep 29;3(9):e523. doi: 10.1371/journal.pntd.0000523.

50.

A combined CXCL10, CXCL8 and H-FABP panel for the staging of human African trypanosomiasis patients.

Hainard A, Tiberti N, Robin X, Lejon V, Ngoyi DM, Matovu E, Enyaru JC, Fouda C, Ndung'u JM, Lisacek F, Müller M, Turck N, Sanchez JC.

PLoS Negl Trop Dis. 2009 Jun 16;3(6):e459. doi: 10.1371/journal.pntd.0000459.

Supplemental Content

Loading ...
Support Center